TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bergentoft Pharma Consulting AB
Closing information (x1000 DKK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,373
|
855
|
457 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
846
|
590
|
266 |
| EBITDA |
846
|
590
|
266 |
| Total assets |
1,963
|
1,235
|
771 |
| Current assets |
1,295
|
1,235
|
771 |
| Current liabilities |
512
|
297
|
156 |
| Equity capital |
1,348
|
874
|
557 |
| - share capital |
33
|
36
|
37 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
68.7%
|
70.8%
|
72.2% |
| Turnover per employee |
1,373
|
855
|
457 |
| Profit as a percentage of turnover |
61.6%
|
69.0%
|
58.2% |
| Return on assets (ROA) |
43.1%
|
47.8%
|
34.5% |
| Current ratio |
252.9%
|
415.8%
|
494.2% |
| Return on equity (ROE) |
62.8%
|
67.5%
|
47.8% |
| Change turnover |
587
|
406
|
-265 |
| Change turnover % |
75%
|
91%
|
-37% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.